lohud.com

Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Regeneron, Bayer extend testing of eye disease treatment

March
27

Regeneron Pharmaceuticals Inc. of Eastview and Germany-based Bayer HealthCare AG said this morning that testing of a possible treatment for an eye disease showed the product reduced retinal thickness and improved eyesight.

The companies said they plan to begin the next phase of testing of the VEGF Trap-Eye during the second half of the year.

The companies have an agreement to develop the product for the treatment of a condition known as wet AMD, an age-related degeneration, and other eye problems.

Regeneron shares were trading at $21.93, up $2.78 or 14.5 percent at 10:17 this morning.

This entry was posted on Tuesday, March 27th, 2007 at 10:35 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Print Print | Email Email

Advertisement

Leave a Reply

Advertisement
About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.

Subscribe

Get blog updates via email:




About the Authors

Categories

Other recent entries




Links

Recently Updated LoHud Blogs
Monthly Archives



Bad Behavior has blocked 1489 access attempts in the last 7 days.